期刊文献+

三维斑点追踪成像评估紫杉醇联合卡铂治疗卵巢癌患者左心室收缩功能 被引量:5

Three-dimensional speckle tracking imaging in evaluation on left ventricular systolic function of Paclitaxel combined with Carboplatin in patients with ovarian cancer
暂未订购
导出
摘要 目的探讨三维斑点追踪成像(3D-STI)评估紫杉醇联合卡铂治疗卵巢癌患者左心室整体收缩功能的应用价值。方法对30例经病理确诊的卵巢癌患者(卵巢癌组)以紫杉醇联合卡铂化学治疗(简称化疗),于化疗前及化疗3、6个周期结束时行3D-STI,获取左心室舒张末期容积(LVEDV)、左心室收缩末期容积(LVESV)、左心室射血分数(LVEF)、球形指数(SPI)、左心室舒张末期质量(LVEDmass)、左心室收缩末期质量(LVESmass)及左心室整体纵向应变(GLS)、整体圆周应变(GCS)、整体径向应变(GRS)、整体面积应变(GAS),并与30名健康志愿者(对照组)进行对比。采用ROC曲线分析各应变参数对卵巢癌患者化疗后心功能受损的诊断效能。结果与对照组比较,卵巢癌组化疗3个和6个周期时LVEDV、LVEF降低,LVEDmass、LVESmass升高,左心室GLS、GCS、GRS、GAS均降低,且6个周期结束时更显著(P均<0.05)。收缩期峰值应变参数诊断卵巢癌患者化疗后心功能的ROC曲线显示,化疗3个周期时GAS的AUC(0.944)及特异度(96.67%)均最高,GLS、GCS的敏感度最高(均为90.00%);化疗6个周期时GAS的AUC(0.953)及特异度(96.67%)最高,GLS的敏感度(93.33%)最高。结论 3D-STI可早期评估紫杉醇联合卡铂治疗卵巢癌患者左心室收缩功能。 Objective To explore the application value of three-dimensional speckle tracking imaging(3 D-STI)in evaluation on changes of left ventricular systolic function caused by Paclitaxel combined with Carboplatin for treatment of ovarian cancer.Methods Thirty patients with pathologically diagnosed ovarian cancer(ovarian cancer group)were selected and treated with Paclitaxel combined with Carboplatin chemotherapy.3 D-STI examination was performed before chemotherapy and at the end of 3 and 6 cycles of chemotherapy to obtain left ventricular end diastolic volume(LVEDV),left ventricular end systolic volume(LVESV),left ventricular ejection fraction(LVEF),spherical index(SPI),left ventricular end diastolic mass(LVEDmass),left ventricular end systolic mass(LVESmass),left ventricular global longitudinal strain(GLS),global circumferential strain(GCS),global radial strain(GRS)and global area strain(GAS),and the indexes compared with those of 30 healthy volunteers(control group).ROC curve was used to analyze the diagnostic efficacy of various strain parameters for cardiac function abnormalities in patients with ovarian cancer after chemotherapy.Results Compared with control group,LVEDV and LVEF decreased,LVEDmass and LVESmass increased,and left ventricular GLS,GCS,GRS and GAS decreased after 3 and 6 cycles of chemotherapy in ovarian cancer group(all P<0.05).ROC curve of systolic peak strain parameters for diagnosis of cardiac function in patients with ovarian cancer after chemotherapy showed that AUC(0.944)and specificity(96.67%)of GAS were the highest at the end of 3 cycles of chemotherapy while GLS and GCS had the highest sensitivity(90.00%).At the end of 6 cycles of chemotherapy,GAS had the highest AUC(0.953)and specificity(96.67%),and GLS had the highest sensitivity(93.33%).Conclusion 3 D-STI can early detect of left ventricular systolic function in patients with ovarian cancer treated with Paclitaxel combined with Carboplatin.
作者 翟子敬 秦文娟 王臻 黄磊 董珊珊 郭雪婷 张彩云 王忠 芦桂林 ZHAI Zijing;QIN Wenjuan;WANG Zhen;HUANG Lei;DONG Shanshan;GUO Xueting;ZHANG Caiyun;WANG Zhong;LU Guilin(Department of Clinical Medicine,School of Medicine,Shihezi University,Shihezi 832008,China;Department of Ultrasound Medicine,First Affiliated Hospital,School of Medicine,Shihezi University,Shihezi 832008,China;nd Department of Cardiology,First Affiliated Hospital,School of Medicine,Shihezi University,Shihezi 832008,China)
出处 《中国介入影像与治疗学》 北大核心 2020年第7期415-420,共6页 Chinese Journal of Interventional Imaging and Therapy
基金 国家自然科学基金(81460075)。
关键词 卵巢肿瘤 心室功能 紫杉醇 卡铂 斑点追踪成像 ovarian neoplasms ventricular function,left Paclitaxel Carboplatin speckle tracking imaging
  • 相关文献

参考文献6

二级参考文献41

  • 1Ferlay J,Shin HR,Bray F,et al.Shin HR,Bray F,et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer,2010,127(2):2893-2917.
  • 2van Hagen P.Preoperative chemoradiotherapy for esophageal or junctional cancer[J].N Engl J Med,2012,366(22):2074-2084.
  • 3Lutkenhaus LJ,Kamphuis M,van Wieringen N,et al.Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer[J].Radiother Oncol,2013,109(2):200-203.
  • 4Feng M,Moran JM,Koelling T,et al.Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer[J].Int J Radiat Oncol Biol Phys,2011,79(1):10-18.
  • 5Ky B,Putt M,Sawaya H,et al.Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin,taxanes,and trastuzumab[J].J Am Coll Cardiol,2014,63(8):809-816.
  • 6Hatakenaka M,Yonezawa M,Nonoshita T,et al.Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer:magnetic resonance evaluation[J].Int J Radiat Oncol Biol Phys,2012,83(1):67-73.
  • 7Honing J,Smit JK,Muijs CT,et al.A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients[J].Ann Oncol,2014,25(3):638-643.
  • 8Adenis A,Mirabel X,Mariette C.Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer[J].Int J Radiat Oncol Biol Phys,2013,86(1):16-17.
  • 9Ruppert BN,Watkins JM,Shirai K,et al.Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer[J].Am J Clin Oncol,2010,33(4):346,352.
  • 10Ren Y,Cao B,Law S,et al.Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression:a prognostic maker of human esophageal squamous cell carcinomas[J].Clin Cancer Res,2005,11(17):6190-6197.

共引文献473

同被引文献25

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部